Symbols / KVUE Stock $17.53 +1.74% Kenvue Inc.

Consumer Defensive • Household & Personal Products • United States • NYQ
KVUE (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Household & Personal Products
CEO Mr. Kirk L. Perry
Exch · Country NYQ · United States
Market Cap 33.66B
Enterprise Value 41.21B
Income 1.47B
Sales 15.12B
FCF (ttm) 1.81B
Book/sh 5.62
Cash/sh 0.55
Employees 21,780
Insider 10d —
IPO May 04, 2023
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 108.55%
P/E 23.07
Forward P/E 14.62
PEG 1.50
P/S 2.23
P/B 3.12
P/C —
EV/EBITDA 12.71
EV/Sales 2.73
Quick Ratio 0.58
Current Ratio 0.96
Debt/Eq 80.58
LT Debt/Eq —
EPS (ttm) 0.76
EPS next Y 1.20
EPS Growth 11.20%
Revenue Growth 3.20%
EPS Gr Q/Q 12.60%
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-17
ROA 6.61%
ROE 14.39%
ROIC —
Gross Margin 58.37%
Oper. Margin 17.83%
Profit Margin 9.72%
Shs Outstand 1.92B
Shs Float 1.91B
Insider Own 0.07%
Instit Own 96.15%
Short Float 3.64%
Short Ratio 3.14
Short Interest 60.26M
52W High 25.17
vs 52W High -30.35%
52W Low 14.02
vs 52W Low 25.04%
Beta 0.57
Impl. Vol. 87.30%
Rel Volume 0.39
Avg Volume 30.81M
Volume 12.01M
Target (mean) $19.58
Tgt Median $19.00
Tgt Low $18.00
Tgt High $23.00
# Analysts 12
Recom Hold
Prev Close $17.23
Price $17.53
Change 1.74%
About

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$19.58
Mean price target
2. Current target
$17.53
Latest analyst target
3. DCF / Fair value
$16.95
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$17.53
Low
$18.00
High
$23.00
Mean
$19.58

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-15 main Citigroup Neutral → Neutral $19
2026-04-14 main Barclays Equal-Weight → Equal-Weight $18
2026-04-07 main UBS Neutral → Neutral $18
2026-03-06 main Barclays Equal-Weight → Equal-Weight $19
2026-02-18 main Canaccord Genuity Hold → Hold $18
2026-02-18 main Citigroup Neutral → Neutral $20
2026-02-18 main UBS Neutral → Neutral $19
2026-01-30 down Jefferies Buy → Hold $18
2025-11-10 main Barclays Equal-Weight → Equal-Weight $18
2025-10-29 down Canaccord Genuity Buy → Hold $15
2025-10-27 main Jefferies Buy → Buy $23
2025-10-10 main JP Morgan Overweight → Overweight $21
2025-10-09 main Citigroup Neutral → Neutral $17
2025-10-08 main B of A Securities Buy → Buy $21
2025-10-08 main UBS Neutral → Neutral $17
2025-10-02 main Goldman Sachs Neutral → Neutral $19
2025-10-01 main Barclays Equal-Weight → Equal-Weight $17
2025-09-26 up Rothschild & Co Neutral → Buy $22
2025-09-23 main Evercore ISI Group In-Line → In-Line $18
2025-09-16 main Citigroup Neutral → Neutral $20
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-10 ALVARADO LUANI Chief Operating Officer — 4,222 — —
2026-03-10 LAWSON CARLTON Officer — 6,157 — —
2026-03-10 STEVENS MEREDITH Chief Operating Officer — 5,169 — —
2026-03-05 ALVARADO LUANI Officer — 4,289 — —
2026-03-05 LAWSON CARLTON Officer — 7,736 — —
2026-03-05 HOWLETT HEATHER Officer — 2,722 — —
2026-03-05 STEVENS MEREDITH Chief Operating Officer — 6,178 — —
2026-03-03 HOWLETT HEATHER Officer — 1,534 — —
2026-02-13 ALVARADO LUANI Officer — 15,942 — —
2026-02-13 LAWSON CARLTON Officer — 39,426 $18.66 $651,365
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
15,124.00
-2.14%
15,455.00
+0.07%
15,444.00
+3.30%
14,950.00
Operating Revenue
15,124.00
-2.14%
15,455.00
+0.07%
15,444.00
+3.30%
14,950.00
Cost Of Revenue
6,332.00
-2.52%
6,496.00
-4.48%
6,801.00
+2.04%
6,665.00
Reconciled Cost Of Revenue
6,332.00
-2.52%
6,496.00
-4.48%
6,801.00
+2.04%
6,665.00
Gross Profit
8,792.00
-1.86%
8,959.00
+3.66%
8,643.00
+4.32%
8,285.00
Operating Expense
6,077.00
-4.00%
6,330.00
+2.93%
6,150.00
+9.88%
5,597.00
Selling General And Administration
6,088.00
-3.81%
6,329.00
+3.06%
6,141.00
+9.02%
5,633.00
Other Operating Expenses
-11.00
-150.00%
22.00
+144.44%
9.00
+125.00%
-36.00
Total Expenses
12,409.00
-3.25%
12,826.00
-0.97%
12,951.00
+5.62%
12,262.00
Operating Income
2,715.00
+3.27%
2,629.00
+5.46%
2,493.00
-7.25%
2,688.00
Total Operating Income As Reported
2,414.00
+31.12%
1,841.00
-26.71%
2,512.00
-6.09%
2,675.00
EBITDA
2,986.00
+20.99%
2,468.00
-22.27%
3,175.00
-3.23%
3,281.00
Normalized EBITDA
3,333.00
+0.76%
3,308.00
+2.70%
3,221.00
-3.42%
3,335.00
Reconciled Depreciation
557.00
-10.45%
622.00
-0.80%
627.00
-2.64%
644.00
EBIT
2,429.00
+31.58%
1,846.00
-27.55%
2,548.00
-3.38%
2,637.00
Total Unusual Items
-347.00
+58.69%
-840.00
-1726.09%
-46.00
+14.81%
-54.00
Total Unusual Items Excluding Goodwill
-347.00
+58.69%
-840.00
-1726.09%
-46.00
+14.81%
-54.00
Special Income Charges
-301.00
+60.76%
-767.00
-4136.84%
19.00
+246.15%
-13.00
Other Special Charges
5.00
+25.00%
4.00
-84.62%
26.00
+471.43%
-7.00
Impairment Of Capital Assets
0.00
-100.00%
556.00
—
0.00
Restructuring And Mergern Acquisition
290.00
+56.76%
185.00
+511.11%
-45.00
0.00
Write Off
23.00
+4.55%
22.00
0.00
-100.00%
12.00
Net Income
1,470.00
+42.72%
1,030.00
-38.10%
1,664.00
-19.38%
2,064.00
Pretax Income
1,999.00
+41.27%
1,415.00
-35.39%
2,190.00
-16.95%
2,637.00
Net Non Operating Interest Income Expense
-379.00
-0.26%
-378.00
-51.20%
-250.00
0.00
Interest Expense Non Operating
430.00
-0.23%
431.00
+20.39%
358.00
0.00
Net Interest Income
-379.00
-0.26%
-378.00
-51.20%
-250.00
0.00
Interest Expense
430.00
-0.23%
431.00
+20.39%
358.00
0.00
Interest Income Non Operating
51.00
-3.77%
53.00
-50.93%
108.00
0.00
Interest Income
51.00
-3.77%
53.00
-50.93%
108.00
0.00
Other Income Expense
-337.00
+59.69%
-836.00
-1477.36%
-53.00
-3.92%
-51.00
Other Non Operating Income Expenses
10.00
+150.00%
4.00
+157.14%
-7.00
-333.33%
3.00
Gain On Sale Of Security
-46.00
+36.99%
-73.00
-12.31%
-65.00
-58.54%
-41.00
Gain On Sale Of Business
17.00
0.00
0.00
—
Tax Provision
529.00
+37.40%
385.00
-26.81%
526.00
-8.20%
573.00
Tax Rate For Calcs
0.00
-2.74%
0.00
+13.37%
0.00
+10.60%
0.00
Tax Effect Of Unusual Items
-91.83
+59.82%
-228.55
-1970.21%
-11.04
+5.79%
-11.72
Net Income Including Noncontrolling Interests
1,470.00
+42.72%
1,030.00
-38.10%
1,664.00
-19.38%
2,064.00
Net Income From Continuing Operation Net Minority Interest
1,470.00
+42.72%
1,030.00
-38.10%
1,664.00
-19.38%
2,064.00
Net Income From Continuing And Discontinued Operation
1,470.00
+42.72%
1,030.00
-38.10%
1,664.00
-19.38%
2,064.00
Net Income Continuous Operations
1,470.00
+42.72%
1,030.00
-38.10%
1,664.00
-19.38%
2,064.00
Normalized Income
1,725.17
+5.10%
1,641.45
-3.39%
1,698.96
-19.34%
2,106.28
Net Income Common Stockholders
1,470.00
+42.72%
1,030.00
-38.10%
1,664.00
-19.38%
2,064.00
Otherunder Preferred Stock Dividend
—
—
—
632.00
Diluted EPS
0.76
+40.74%
0.54
-40.00%
0.90
-17.63%
1.09
Basic EPS
0.76
+40.74%
0.54
-40.00%
0.90
-17.63%
1.09
Basic Average Shares
1,917.00
+0.10%
1,915.00
+3.74%
1,846.00
-2.27%
1,888.97
Diluted Average Shares
1,924.00
+0.05%
1,923.00
+3.95%
1,850.00
-2.06%
1,888.97
Diluted NI Availto Com Stockholders
1,470.00
+42.72%
1,030.00
-38.10%
1,664.00
-19.38%
2,064.00
Earnings From Equity Interest
—
—
—
—
Gain On Sale Of PPE
—
-6.00
-166.67%
9.00
+212.50%
-8.00
Other Taxes
0.00
+100.00%
-21.00
0.00
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
27,076.00
+5.76%
25,601.00
-8.08%
27,851.00
Current Assets
5,697.00
+3.11%
5,525.00
-9.99%
6,138.00
Cash Cash Equivalents And Short Term Investments
1,062.00
-0.75%
1,070.00
-22.58%
1,382.00
Cash And Cash Equivalents
1,062.00
-0.75%
1,070.00
-22.58%
1,382.00
Receivables
2,814.00
+5.83%
2,659.00
+0.72%
2,640.00
Accounts Receivable
2,382.00
+10.02%
2,165.00
+4.44%
2,073.00
Gross Accounts Receivable
2,408.00
+9.90%
2,191.00
+4.43%
2,098.00
Allowance For Doubtful Accounts Receivable
-26.00
+0.00%
-26.00
-4.00%
-25.00
Other Receivables
432.00
-12.55%
494.00
-12.87%
567.00
Inventory
1,666.00
+4.71%
1,591.00
-14.05%
1,851.00
Raw Materials
275.00
+0.36%
274.00
-9.87%
304.00
Work In Process
103.00
+1.98%
101.00
-12.17%
115.00
Finished Goods
1,288.00
+5.92%
1,216.00
-15.08%
1,432.00
Other Current Assets
155.00
-24.39%
205.00
-22.64%
265.00
Total Non Current Assets
21,379.00
+6.49%
20,076.00
-7.54%
21,713.00
Net PPE
2,212.00
+19.63%
1,849.00
-9.45%
2,042.00
Gross PPE
5,231.00
+14.97%
4,550.00
-27.12%
6,243.00
Accumulated Depreciation
-3,019.00
-11.77%
-2,701.00
+35.71%
-4,201.00
Properties
0.00
0.00
0.00
Land And Improvements
60.00
+5.26%
57.00
-25.00%
76.00
Buildings And Improvements
1,853.00
+15.88%
1,599.00
-8.58%
1,749.00
Machinery Furniture Equipment
2,723.00
+15.77%
2,352.00
-40.27%
3,938.00
Construction In Progress
595.00
+9.78%
542.00
+12.92%
480.00
Goodwill And Other Intangible Assets
18,203.00
+5.12%
17,317.00
-8.33%
18,890.00
Goodwill
9,509.00
+7.53%
8,843.00
-4.62%
9,271.00
Other Intangible Assets
8,694.00
+2.60%
8,474.00
-11.90%
9,619.00
Non Current Deferred Assets
237.00
+28.80%
184.00
+16.46%
158.00
Non Current Deferred Taxes Assets
237.00
+28.80%
184.00
+16.46%
158.00
Other Non Current Assets
727.00
+0.14%
726.00
+16.53%
623.00
Total Liabilities Net Minority Interest
16,311.00
+2.37%
15,933.00
-4.25%
16,640.00
Current Liabilities
5,945.00
+3.59%
5,739.00
+4.71%
5,481.00
Payables And Accrued Expenses
4,106.00
+7.32%
3,826.00
-13.67%
4,432.00
Payables
2,600.00
+7.88%
2,410.00
-12.17%
2,744.00
Accounts Payable
2,473.00
+9.72%
2,254.00
-9.44%
2,489.00
Current Accrued Expenses
1,506.00
+6.36%
1,416.00
-16.11%
1,688.00
Employee Benefits
340.00
-0.58%
342.00
-5.00%
360.00
Pensionand Other Post Retirement Benefit Plans Current
343.00
+5.54%
325.00
-19.95%
406.00
Total Tax Payable
127.00
-18.59%
156.00
-38.82%
255.00
Income Tax Payable
105.00
+41.89%
74.00
-47.89%
142.00
Current Debt And Capital Lease Obligation
1,496.00
-5.79%
1,588.00
+146.97%
643.00
Current Debt
1,453.00
-6.38%
1,552.00
+159.10%
599.00
Other Current Borrowings
753.00
+0.13%
752.00
—
Current Capital Lease Obligation
43.00
+19.44%
36.00
-18.18%
44.00
Total Non Current Liabilities Net Minority Interest
10,366.00
+1.69%
10,194.00
-8.65%
11,159.00
Long Term Debt And Capital Lease Obligation
7,178.00
+0.64%
7,132.00
-8.38%
7,784.00
Long Term Debt
6,938.00
+0.01%
6,937.00
-9.76%
7,687.00
Long Term Capital Lease Obligation
240.00
+23.08%
195.00
+101.03%
97.00
Tradeand Other Payables Non Current
354.00
+7.93%
328.00
-0.30%
329.00
Non Current Deferred Liabilities
2,354.00
+4.11%
2,261.00
-13.74%
2,621.00
Non Current Deferred Taxes Liabilities
2,354.00
+4.11%
2,261.00
-13.74%
2,621.00
Other Non Current Liabilities
—
-1.00
—
Stockholders Equity
10,765.00
+11.35%
9,668.00
-13.76%
11,211.00
Common Stock Equity
10,765.00
+11.35%
9,668.00
-13.76%
11,211.00
Capital Stock
19.00
+0.00%
19.00
+0.00%
19.00
Common Stock
19.00
+0.00%
19.00
+0.00%
19.00
Preferred Stock
0.00
0.00
0.00
Share Issued
1,936.50
+0.60%
1,924.98
+0.50%
1,915.41
Ordinary Shares Number
1,916.12
+0.12%
1,913.77
-0.07%
1,915.06
Treasury Shares Number
20.39
+81.89%
11.21
+3102.41%
0.35
Additional Paid In Capital
16,348.00
+1.35%
16,130.00
-0.11%
16,147.00
Retained Earnings
-204.00
-119.35%
-93.00
-121.68%
429.00
Gains Losses Not Affecting Retained Earnings
-4,959.00
+19.31%
-6,146.00
-14.30%
-5,377.00
Treasury Stock
439.00
+81.40%
242.00
+3357.14%
7.00
Other Equity Adjustments
-4,959.00
+19.31%
-6,146.00
-14.30%
-5,377.00
Total Equity Gross Minority Interest
10,765.00
+11.35%
9,668.00
-13.76%
11,211.00
Total Capitalization
17,703.00
+6.61%
16,605.00
-12.13%
18,898.00
Working Capital
-248.00
-15.89%
-214.00
-132.57%
657.00
Invested Capital
19,156.00
+5.50%
18,157.00
-6.87%
19,497.00
Total Debt
8,674.00
-0.53%
8,720.00
+3.48%
8,427.00
Net Debt
7,329.00
-1.21%
7,419.00
+7.46%
6,904.00
Capital Lease Obligations
283.00
+22.51%
231.00
+63.83%
141.00
Net Tangible Assets
-7,438.00
+2.76%
-7,649.00
+0.39%
-7,679.00
Tangible Book Value
-7,438.00
+2.76%
-7,649.00
+0.39%
-7,679.00
Commercial Paper
700.00
-12.50%
800.00
+33.56%
599.00
Foreign Currency Translation Adjustments
—
—
—
Minimum Pension Liabilities
—
—
—
Non Current Accrued Expenses
140.00
+6.06%
132.00
+103.08%
65.00
Other Equity Interest
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
2,197.00
+24.19%
1,769.00
-44.16%
3,168.00
+25.47%
2,525.00
Cash Flow From Continuing Operating Activities
2,197.00
+24.19%
1,769.00
-44.16%
3,168.00
+25.47%
2,525.00
Net Income From Continuing Operations
1,470.00
+42.72%
1,030.00
-38.10%
1,664.00
-19.38%
2,064.00
Depreciation Amortization Depletion
557.00
-10.45%
622.00
-0.80%
627.00
-2.64%
644.00
Depreciation
300.00
-15.01%
353.00
+15.74%
305.00
+3.04%
296.00
Amortization Cash Flow
257.00
-4.46%
269.00
-16.46%
322.00
-7.47%
348.00
Depreciation And Amortization
557.00
-10.45%
622.00
-0.80%
627.00
-2.64%
644.00
Amortization Of Intangibles
257.00
-4.46%
269.00
-16.46%
322.00
-7.47%
348.00
Other Non Cash Items
67.00
-2.90%
69.00
+7000.00%
-1.00
-107.14%
14.00
Stock Based Compensation
136.00
-46.46%
254.00
+35.11%
188.00
+37.23%
137.00
Provisionand Write Offof Assets
—
—
—
9.00
Asset Impairment Charge
23.00
-96.02%
578.00
0.00
-100.00%
12.00
Deferred Tax
-108.00
+62.11%
-285.00
-150.00%
-114.00
-163.33%
180.00
Deferred Income Tax
-108.00
+62.11%
-285.00
-150.00%
-114.00
-163.33%
180.00
Operating Gains Losses
—
72.00
+928.57%
7.00
+800.00%
-1.00
Gain Loss On Investment Securities
—
72.00
+928.57%
7.00
+800.00%
-1.00
Change In Working Capital
52.00
+109.11%
-571.00
-171.64%
797.00
+251.81%
-525.00
Change In Receivables
-112.00
+48.62%
-218.00
-595.45%
44.00
+130.99%
-142.00
Changes In Account Receivables
-112.00
+48.62%
-218.00
-595.45%
44.00
+130.99%
-142.00
Change In Inventory
-12.00
-106.59%
182.00
-47.85%
349.00
+159.97%
-582.00
Change In Payables And Accrued Expense
14.00
+102.35%
-597.00
-153.16%
1,123.00
+3643.33%
30.00
Change In Accrued Expense
—
—
1,064.00
+6358.82%
-17.00
Change In Payable
14.00
+102.35%
-597.00
-153.16%
1,123.00
+3643.33%
30.00
Change In Account Payable
41.00
+107.65%
-536.00
-136.86%
1,454.00
+4054.29%
35.00
Change In Other Working Capital
43.00
+59.26%
27.00
+134.62%
-78.00
-4000.00%
2.00
Change In Other Current Assets
122.00
+817.65%
-17.00
+96.04%
-429.00
-460.50%
119.00
Change In Other Current Liabilities
-3.00
-105.77%
52.00
+124.53%
-212.00
-541.67%
48.00
Investing Cash Flow
-436.00
-2.59%
-425.00
+12.91%
-488.00
-25.13%
-390.00
Cash Flow From Continuing Investing Activities
-436.00
-2.59%
-425.00
+12.91%
-488.00
-25.13%
-390.00
Net PPE Purchase And Sale
-475.00
-9.45%
-434.00
+7.46%
-469.00
-25.07%
-375.00
Purchase Of PPE
-475.00
-9.45%
-434.00
+7.46%
-469.00
-25.07%
-375.00
Capital Expenditure
-475.00
-9.45%
-434.00
+7.46%
-469.00
-25.07%
-375.00
Net Investment Purchase And Sale
—
—
—
-5.00
Purchase Of Investment
—
—
—
-5.00
Net Business Purchase And Sale
—
—
—
-10.00
Purchase Of Business
—
—
—
-18.00
Net Other Investing Changes
39.00
+333.33%
9.00
+147.37%
-19.00
-26.67%
-15.00
Financing Cash Flow
-1,837.00
-17.38%
-1,565.00
+38.07%
-2,527.00
-59.63%
-1,583.00
Cash Flow From Continuing Financing Activities
-1,837.00
-17.38%
-1,565.00
+38.07%
-2,527.00
-59.63%
-1,583.00
Net Issuance Payments Of Debt
-150.00
-195.54%
157.00
-98.10%
8,260.00
+58900.00%
14.00
Issuance Of Debt
746.00
+375.16%
157.00
-98.10%
8,260.00
+58900.00%
14.00
Repayment Of Debt
-896.00
0.00
0.00
—
Long Term Debt Issuance
746.00
0.00
-100.00%
7,686.00
0.00
Long Term Debt Payments
-750.00
0.00
0.00
—
Net Long Term Debt Issuance
-4.00
0.00
-100.00%
7,686.00
0.00
Short Term Debt Issuance
—
157.00
-72.65%
574.00
+4000.00%
14.00
Short Term Debt Payments
-146.00
—
—
—
Net Short Term Debt Issuance
-146.00
-192.99%
157.00
-72.65%
574.00
+4000.00%
14.00
Net Common Stock Issuance
-197.00
+16.17%
-235.00
-105.55%
4,234.00
0.00
Common Stock Payments
-197.00
+16.17%
-235.00
-3257.14%
-7.00
0.00
Common Stock Dividend Paid
-1,581.00
-1.87%
-1,552.00
+89.34%
-14,554.00
0.00
Cash Dividends Paid
-1,581.00
-1.87%
-1,552.00
+89.34%
-14,554.00
0.00
Repurchase Of Capital Stock
-197.00
+16.17%
-235.00
-3257.14%
-7.00
0.00
Net Other Financing Charges
91.00
+40.00%
65.00
+113.92%
-467.00
+70.76%
-1,597.00
Changes In Cash
-76.00
+65.61%
-221.00
-244.44%
153.00
-72.28%
552.00
Effect Of Exchange Rate Changes
68.00
+174.73%
-91.00
-4450.00%
-2.00
+96.72%
-61.00
Beginning Cash Position
1,070.00
-22.58%
1,382.00
+12.27%
1,231.00
+66.35%
740.00
End Cash Position
1,062.00
-0.75%
1,070.00
-22.58%
1,382.00
+12.27%
1,231.00
Free Cash Flow
1,722.00
+28.99%
1,335.00
-50.54%
2,699.00
+25.53%
2,150.00
Interest Paid Supplemental Data
440.00
+0.23%
439.00
+95.98%
224.00
0.00
Income Tax Paid Supplemental Data
595.00
-26.54%
810.00
+15.88%
699.00
+121.20%
316.00
Change In Income Tax Payable
-27.00
+55.74%
-61.00
+81.57%
-331.00
-6520.00%
-5.00
Change In Tax Payable
-27.00
+55.74%
-61.00
+81.57%
-331.00
-6520.00%
-5.00
Common Stock Issuance
0.00
0.00
-100.00%
4,241.00
0.00
Earnings Losses From Equity Investments
—
—
—
—
Issuance Of Capital Stock
0.00
0.00
-100.00%
4,241.00
0.00
Sale Of Business
—
—
—
8.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category